Related Experiment Video
Updated: Sep 15, 2025

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
Published on: March 17, 2023
p21-activated kinases (PAKs) regulate FGF1/PDE4D antilipolytic pathway and insulin resistance in adipocytes
Judith Seigner1, Johannes Krier1, David Spähn2
1Institute for Diabetes Research and Metabolic Diseases of the Helmholtz Center Munich, Tübingen, Germany; Department of Internal Medicine IV, Division of Diabetology, Endocrinology and Nephrology, University Hospital of Tübingen, Tübingen, Germany; German Center for Diabetes Research (DZD), Munich-Neuherberg, Germany.
Abstract:
Increasing evidence suggests that adipose tissue plays a key role in the development, progression, and treatment of the globally epidemic disease type 2 diabetes (T2D). For example, adipose tissue dysfunction, lipotoxicity, and insulin resistance (IR) are major contributors and targets for the treatment of T2D. We previously identified the Fibroblast growth factor 1 (FGF1)/Phosphodiesterase 4D (PDE4D) pathway, which lowers plasma glucose concentration by suppressing lipolysis in adipose tissue and ultimately regulating hepatic glucose production in obese insulin-resistant mice. While phosphorylation of PDE4D is critical for its activity, the upstream signaling mechanisms remain unclear. In this study, we identified p21-activated kinases (PAKs) as regulator of PDE4D phosphorylation and suppression of lipolysis by FGF1. Inhibition of PAK-induced cAMP accumulation prevented antilipolytic function of FGF1, and reversed suppression of lipolysis caused by PDE4D overexpression, linking PAKs to the regulation of cAMP by PDE4D in murine adipocytes in vitro. Chronic inhibition of PAKs decreased lipid accumulation in both mouse and human adipocyte cultures, lowered expression of adipogenic markers, and induced IR, suggesting a previously unidentified role of PAKs in adipocyte function and differentiation. We conclude that PAKs play a crucial role in regulating the FGF1/PDE4D antilipolytic pathway, adipogenesis and IR, thereby highlighting their potential as therapeutic targets for T2D.
Insights
p21-activated kinases (PAKs) regulate the Fibroblast growth factor 1/Phosphodiesterase 4D pathway, impacting fat breakdown and glucose levels. This discovery offers new therapeutic targets for type 2 diabetes (T2D) and insulin resistance (IR).
Area of Science:
- Metabolism
- Endocrinology
- Cell Biology
Background:
- Adipose tissue dysfunction, lipotoxicity, and insulin resistance (IR) are central to type 2 diabetes (T2D).
- The Fibroblast growth factor 1 (FGF1)/Phosphodiesterase 4D (PDE4D) pathway regulates glucose and lipid metabolism by suppressing lipolysis.
- Upstream regulators of PDE4D phosphorylation, crucial for its activity, were previously unknown.
Purpose of the Study:
- To identify upstream signaling mechanisms regulating PDE4D phosphorylation and the FGF1/PDE4D pathway.
- To investigate the role of p21-activated kinases (PAKs) in adipocyte function, differentiation, and their link to T2D.
Main Methods:
- In vitro studies using murine adipocytes to examine the effects of FGF1 and PAK inhibition on PDE4D phosphorylation, cAMP levels, and lipolysis.
- Chronic inhibition of PAKs in mouse and human adipocyte cultures to assess lipid accumulation, adipogenic marker expression, and IR.
Main Results:
- PAKs were identified as key regulators of PDE4D phosphorylation and FGF1-mediated suppression of lipolysis.
- Inhibition of PAKs disrupted FGF1's antilipolytic function and altered cAMP regulation by PDE4D.
- Chronic PAK inhibition reduced adiposity, decreased adipogenic markers, and induced IR in adipocytes.
Conclusions:
- PAKs are critical regulators of the FGF1/PDE4D antilipolytic pathway in adipocytes.
- PAKs play a significant role in adipogenesis and the development of insulin resistance.
- PAKs represent a potential therapeutic target for managing T2D and related metabolic disorders.
More Related Videos
Related Concept Videos
Insulin: The Receptor and Signaling Pathways
PI3K/mTOR/AKT Signaling Pathway
cAMP-dependent Protein Kinase Pathways
GPCRs Regulate Adenylyl Cylase Activity
Regulation of Angiogenesis and Blood Supply
The JAK-STAT Signaling Pathway

